1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Ophthalmic Anti-infective Preparations Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Antibacterial 1.2.3 Antiviral 1.2.4 Antifungal 1.2.5 Anti-parasitic 1.2.6 Others 1.3 Market Segment by Application 1.3.1 Global Ophthalmic Anti-infective Preparations Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Hospital Use 1.3.3 Clinic Use 1.3.4 Household 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Ophthalmic Anti-infective Preparations Market Size (2017-2028) 2.1.1 Global Ophthalmic Anti-infective Preparations Revenue (2017-2028) 2.1.2 Global Ophthalmic Anti-infective Preparations Sales (2017-2028) 2.2 Global Ophthalmic Anti-infective Preparations Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Ophthalmic Anti-infective Preparations Sales by Regions (2017-2022) 2.2.2 Global Ophthalmic Anti-infective Preparations Revenue by Regions (2017-2022) 2.3 Global Ophthalmic Anti-infective Preparations Market Size Forecast by Region 2.3.1 Global Ophthalmic Anti-infective Preparations Sales Forecast by Region (2023-2028) 2.3.2 Global Ophthalmic Anti-infective Preparations Revenue Forecast by Region (2023-2028) 2.4 Global Top Ophthalmic Anti-infective Preparations Regions (Countries) Ranking by Market Size 2.5 Ophthalmic Anti-infective Preparations Market Dynamics 2.5.1 Ophthalmic Anti-infective Preparations Market Trends 2.5.2 Ophthalmic Anti-infective Preparations Market Drivers 2.5.3 Ophthalmic Anti-infective Preparations Market Challenges 2.5.4 Ophthalmic Anti-infective Preparations Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Ophthalmic Anti-infective Preparations Manufacturers by Sales (2017-2022) 3.1.1 Global Ophthalmic Anti-infective Preparations Sales by Manufacturers (2017-2022) 3.1.2 Global Ophthalmic Anti-infective Preparations Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Ophthalmic Anti-infective Preparations Sales in 2021 3.2 Global Top Manufacturers Ophthalmic Anti-infective Preparations by Revenue 3.2.1 Global Ophthalmic Anti-infective Preparations Revenue by Manufacturers (2017-2022) 3.2.2 Top Ophthalmic Anti-infective Preparations Manufacturers Covered: Ranking by Revenue 3.2.3 Global Ophthalmic Anti-infective Preparations Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Ophthalmic Anti-infective Preparations Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ophthalmic Anti-infective Preparations as of 2021) 3.4 Global Ophthalmic Anti-infective Preparations Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Ophthalmic Anti-infective Preparations Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Ophthalmic Anti-infective Preparations Market 3.7 Key Manufacturers Ophthalmic Anti-infective Preparations Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Ophthalmic Anti-infective Preparations Market Size by Type 4.1 Global Ophthalmic Anti-infective Preparations Historic Market Review by Type (2017-2022) 4.1.1 Global Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2022) 4.1.2 Global Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2017-2022) 4.1.3 Ophthalmic Anti-infective Preparations Price by Type (2017-2022) 4.2 Global Ophthalmic Anti-infective Preparations Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Ophthalmic Anti-infective Preparations Sales Forecast by Type (2023-2028) 4.2.2 Global Ophthalmic Anti-infective Preparations Revenue Forecast by Type (2023-2028) 4.2.3 Ophthalmic Anti-infective Preparations Price Forecast by Type (2023-2028) 5 Global Ophthalmic Anti-infective Preparations Market Size by Application 5.1 Global Ophthalmic Anti-infective Preparations Historic Market Review by Application (2017-2022) 5.1.1 Global Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2022) 5.1.2 Global Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2017-2022) 5.1.3 Ophthalmic Anti-infective Preparations Price by Application (2017-2022) 5.2 Global Ophthalmic Anti-infective Preparations Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Ophthalmic Anti-infective Preparations Sales Forecast by Application (2023-2028) 5.2.2 Global Ophthalmic Anti-infective Preparations Revenue Forecast by Application (2023-2028) 5.2.3 Ophthalmic Anti-infective Preparations Price Forecast by Application (2023-2028) 6 North America 6.1 North America Ophthalmic Anti-infective Preparations Sales Breakdown by Company 6.1.1 North America Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) 6.1.2 North America Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) 6.2 North America Ophthalmic Anti-infective Preparations Market Size by Type 6.2.1 North America Ophthalmic Anti-infective Preparations Sales by Type (2017-2028) 6.2.2 North America Ophthalmic Anti-infective Preparations Revenue by Type (2017-2028) 6.3 North America Ophthalmic Anti-infective Preparations Market Size by Application 6.3.1 North America Ophthalmic Anti-infective Preparations Sales by Application (2017-2028) 6.3.2 North America Ophthalmic Anti-infective Preparations Revenue by Application (2017-2028) 6.4 North America Ophthalmic Anti-infective Preparations Market Size by Country 6.4.1 North America Ophthalmic Anti-infective Preparations Sales by Country (2017-2028) 6.4.2 North America Ophthalmic Anti-infective Preparations Revenue by Country (2017-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Ophthalmic Anti-infective Preparations Sales Breakdown by Company 7.1.1 Europe Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) 7.1.2 Europe Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) 7.2 Europe Ophthalmic Anti-infective Preparations Market Size by Type 7.2.1 Europe Ophthalmic Anti-infective Preparations Sales by Type (2017-2028) 7.2.2 Europe Ophthalmic Anti-infective Preparations Revenue by Type (2017-2028) 7.3 Europe Ophthalmic Anti-infective Preparations Market Size by Application 7.3.1 Europe Ophthalmic Anti-infective Preparations Sales by Application (2017-2028) 7.3.2 Europe Ophthalmic Anti-infective Preparations Revenue by Application (2017-2028) 7.4 Europe Ophthalmic Anti-infective Preparations Market Size by Country 7.4.1 Europe Ophthalmic Anti-infective Preparations Sales by Country (2017-2028) 7.4.2 Europe Ophthalmic Anti-infective Preparations Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Ophthalmic Anti-infective Preparations Sales Breakdown by Company 8.1.1 Asia Pacific Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) 8.1.2 Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) 8.2 Asia Pacific Ophthalmic Anti-infective Preparations Market Size by Type 8.2.1 Asia Pacific Ophthalmic Anti-infective Preparations Sales by Type (2017-2028) 8.2.2 Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Type (2017-2028) 8.3 Asia Pacific Ophthalmic Anti-infective Preparations Market Size by Application 8.3.1 Asia Pacific Ophthalmic Anti-infective Preparations Sales by Application (2017-2028) 8.3.2 Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Application (2017-2028) 8.4 Asia Pacific Ophthalmic Anti-infective Preparations Market Size by Region 8.4.1 Asia Pacific Ophthalmic Anti-infective Preparations Sales by Region 8.4.2 Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 8.4.12 Philippines 8.4.13 Vietnam 9 Latin America 9.1 Latin America Ophthalmic Anti-infective Preparations Sales Breakdown by Company 9.1.1 Latin America Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) 9.1.2 Latin America Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) 9.2 Latin America Ophthalmic Anti-infective Preparations Market Size by Type 9.2.1 Latin America Ophthalmic Anti-infective Preparations Sales by Type (2017-2028) 9.2.2 Latin America Ophthalmic Anti-infective Preparations Revenue by Type (2017-2028) 9.3 Latin America Ophthalmic Anti-infective Preparations Market Size by Application 9.3.1 Latin America Ophthalmic Anti-infective Preparations Sales by Application (2017-2028) 9.3.2 Latin America Ophthalmic Anti-infective Preparations Revenue by Application (2017-2028) 9.4 Latin America Ophthalmic Anti-infective Preparations Market Size by Country 9.4.1 Latin America Ophthalmic Anti-infective Preparations Sales by Country (2017-2028) 9.4.2 Latin America Ophthalmic Anti-infective Preparations Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Ophthalmic Anti-infective Preparations Sales Breakdown by Company 10.1.1 Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) 10.1.2 Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) 10.2 Middle East and Africa Ophthalmic Anti-infective Preparations Market Size by Type 10.2.1 Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Type (2017-2028) 10.2.2 Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Type (2017-2028) 10.3 Middle East and Africa Ophthalmic Anti-infective Preparations Market Size by Application 10.3.1 Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Application (2017-2028) 10.3.2 Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Application (2017-2028) 10.4 Middle East and Africa Ophthalmic Anti-infective Preparations Market Size by Country 10.4.1 Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Country (2017-2028) 10.4.2 Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Company Profiles 11.1 Allergan PLC 11.1.1 Allergan PLC Corporation Information 11.1.2 Allergan PLC Overview 11.1.3 Allergan PLC Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 Allergan PLC Ophthalmic Anti-infective Preparations Products and Services 11.1.5 Allergan PLC Ophthalmic Anti-infective Preparations SWOT Analysis 11.1.6 Allergan PLC Recent Developments 11.2 Bayer AG 11.2.1 Bayer AG Corporation Information 11.2.2 Bayer AG Overview 11.2.3 Bayer AG Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 Bayer AG Ophthalmic Anti-infective Preparations Products and Services 11.2.5 Bayer AG Ophthalmic Anti-infective Preparations SWOT Analysis 11.2.6 Bayer AG Recent Developments 11.3 F. Hoffmann-La Roche AG 11.3.1 F. Hoffmann-La Roche AG Corporation Information 11.3.2 F. Hoffmann-La Roche AG Overview 11.3.3 F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Products and Services 11.3.5 F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations SWOT Analysis 11.3.6 F. Hoffmann-La Roche AG Recent Developments 11.4 Johnson and Johnson Vision Care Inc 11.4.1 Johnson and Johnson Vision Care Inc Corporation Information 11.4.2 Johnson and Johnson Vision Care Inc Overview 11.4.3 Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Products and Services 11.4.5 Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations SWOT Analysis 11.4.6 Johnson and Johnson Vision Care Inc Recent Developments 11.5 Kyowa Kirin Co., Ltd 11.5.1 Kyowa Kirin Co., Ltd Corporation Information 11.5.2 Kyowa Kirin Co., Ltd Overview 11.5.3 Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Products and Services 11.5.5 Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations SWOT Analysis 11.5.6 Kyowa Kirin Co., Ltd Recent Developments 11.6 Novartis International AG 11.6.1 Novartis International AG Corporation Information 11.6.2 Novartis International AG Overview 11.6.3 Novartis International AG Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 Novartis International AG Ophthalmic Anti-infective Preparations Products and Services 11.6.5 Novartis International AG Ophthalmic Anti-infective Preparations SWOT Analysis 11.6.6 Novartis International AG Recent Developments 11.7 Pfizer, Inc. 11.7.1 Pfizer, Inc. Corporation Information 11.7.2 Pfizer, Inc. Overview 11.7.3 Pfizer, Inc. Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Pfizer, Inc. Ophthalmic Anti-infective Preparations Products and Services 11.7.5 Pfizer, Inc. Ophthalmic Anti-infective Preparations SWOT Analysis 11.7.6 Pfizer, Inc. Recent Developments 11.8 Regeneron Pharmaceuticals, Inc. 11.8.1 Regeneron Pharmaceuticals, Inc. Corporation Information 11.8.2 Regeneron Pharmaceuticals, Inc. Overview 11.8.3 Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Products and Services 11.8.5 Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations SWOT Analysis 11.8.6 Regeneron Pharmaceuticals, Inc. Recent Developments 11.9 Santen Pharmaceuticals Co., Ltd. 11.9.1 Santen Pharmaceuticals Co., Ltd. Corporation Information 11.9.2 Santen Pharmaceuticals Co., Ltd. Overview 11.9.3 Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Products and Services 11.9.5 Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations SWOT Analysis 11.9.6 Santen Pharmaceuticals Co., Ltd. Recent Developments 11.10 Shire PLC 11.10.1 Shire PLC Corporation Information 11.10.2 Shire PLC Overview 11.10.3 Shire PLC Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.10.4 Shire PLC Ophthalmic Anti-infective Preparations Products and Services 11.10.5 Shire PLC Ophthalmic Anti-infective Preparations SWOT Analysis 11.10.6 Shire PLC Recent Developments 11.11 Bausch Health 11.11.1 Bausch Health Corporation Information 11.11.2 Bausch Health Overview 11.11.3 Bausch Health Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.11.4 Bausch Health Ophthalmic Anti-infective Preparations Products and Services 11.11.5 Bausch Health Recent Developments 11.12 Lupin Pharmaceuticals 11.12.1 Lupin Pharmaceuticals Corporation Information 11.12.2 Lupin Pharmaceuticals Overview 11.12.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.12.4 Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Products and Services 11.12.5 Lupin Pharmaceuticals Recent Developments 11.13 Apotex 11.13.1 Apotex Corporation Information 11.13.2 Apotex Overview 11.13.3 Apotex Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.13.4 Apotex Ophthalmic Anti-infective Preparations Products and Services 11.13.5 Apotex Recent Developments 11.14 Akorn 11.14.1 Akorn Corporation Information 11.14.2 Akorn Overview 11.14.3 Akorn Ophthalmic Anti-infective Preparations Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.14.4 Akorn Ophthalmic Anti-infective Preparations Products and Services 11.14.5 Akorn Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Ophthalmic Anti-infective Preparations Value Chain Analysis 12.2 Ophthalmic Anti-infective Preparations Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Ophthalmic Anti-infective Preparations Production Mode & Process 12.4 Ophthalmic Anti-infective Preparations Sales and Marketing 12.4.1 Ophthalmic Anti-infective Preparations Sales Channels 12.4.2 Ophthalmic Anti-infective Preparations Distributors 12.5 Ophthalmic Anti-infective Preparations Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Ophthalmic Anti-infective Preparations Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Antibacterial Table 3. Major Manufacturers of Antiviral Table 4. Major Manufacturers of Antifungal Table 5. Major Manufacturers of Anti-parasitic Table 6. Major Manufacturers of Others Table 7. Global Ophthalmic Anti-infective Preparations Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Ophthalmic Anti-infective Preparations Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 9. Global Ophthalmic Anti-infective Preparations Sales by Region (2017-2022) & (MT) Table 10. Global Ophthalmic Anti-infective Preparations Sales Market Share by Region (2017-2022) Table 11. Global Ophthalmic Anti-infective Preparations Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Region (2017-2022) Table 13. Global Ophthalmic Anti-infective Preparations Sales Forecast by Region (2023-2028) & (MT) Table 14. Global Ophthalmic Anti-infective Preparations Sales Market Share Forecast by Region (2023-2028) Table 15. Global Ophthalmic Anti-infective Preparations Revenue Forecast by Region (2023-2028) & (US$ Million) Table 16. Global Ophthalmic Anti-infective Preparations Revenue Market Share Forecast by Region (2023-2028) Table 17. Top Ophthalmic Anti-infective Preparations Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 18. Ophthalmic Anti-infective Preparations Market Trends Table 19. Ophthalmic Anti-infective Preparations Market Drivers Table 20. Ophthalmic Anti-infective Preparations Market Challenges Table 21. Ophthalmic Anti-infective Preparations Market Restraints Table 22. Global Ophthalmic Anti-infective Preparations Sales by Manufacturers (2017-2022) & (MT) Table 23. Global Ophthalmic Anti-infective Preparations Sales Share by Manufacturers (2017-2022) Table 24. Global Ophthalmic Anti-infective Preparations Revenue by Manufacturers (2017-2022) & (US$ Million) Table 25. Ranking of Global Top Ophthalmic Anti-infective Preparations Manufacturers by Revenue (US$ Million) in 2021 Table 26. Ophthalmic Anti-infective Preparations Revenue Share by Manufacturers (2017-2022) Table 27. Global Ophthalmic Anti-infective Preparations Manufacturers Market Concentration Ratio (CR5 and HHI) Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ophthalmic Anti-infective Preparations as of 2021) Table 29. Key Manufacturers Ophthalmic Anti-infective Preparations Average Selling Price (ASP) & (2017-2022) & (USD/MT) Table 30. Key Manufacturers Ophthalmic Anti-infective Preparations Plants/Factories Distribution Table 31. Key Manufacturers Ophthalmic Anti-infective Preparations Area Served Table 32. Date of Key Manufacturers Enter into Ophthalmic Anti-infective Preparations Market Table 33. Key Manufacturers Ophthalmic Anti-infective Preparations Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Ophthalmic Anti-infective Preparations Sales (MT) by Type (2017-2022) Table 36. Global Ophthalmic Anti-infective Preparations Sales Share by Type (2017-2022) Table 37. Global Ophthalmic Anti-infective Preparations Revenue (US$ Million) Market Share by Type (2017-2022) Table 38. Global Ophthalmic Anti-infective Preparations Price (MT) by Type (2017-2022) Table 39. Global Ophthalmic Anti-infective Preparations Sales (MT) by Type (2023-2028) Table 40. Global Ophthalmic Anti-infective Preparations Sales Share by Type (2023-2028) Table 41. Global Ophthalmic Anti-infective Preparations Revenue (US$ Million) Market Share by Type (2023-2028) Table 42. Global Ophthalmic Anti-infective Preparations Revenue Share by Type (2023-2028) Table 43. Global Ophthalmic Anti-infective Preparations Price (MT) by Type (2023-2028) Table 44. Global Ophthalmic Anti-infective Preparations Sales (MT) by Application (2017-2022) Table 45. Global Ophthalmic Anti-infective Preparations Sales Share by Application (2017-2022) Table 46. Global Ophthalmic Anti-infective Preparations Revenue (US$ Million) Market Share by Application (2017-2022) Table 47. Global Ophthalmic Anti-infective Preparations Price (MT) by Application (2017-2022) Table 48. Global Ophthalmic Anti-infective Preparations Sales (MT) by Application (2023-2028) Table 49. Global Ophthalmic Anti-infective Preparations Sales Share by Application (2023-2028) Table 50. Global Ophthalmic Anti-infective Preparations Revenue (US$ Million) Market Share by Application (2023-2028) Table 51. Global Ophthalmic Anti-infective Preparations Revenue Share by Application (2023-2028) Table 52. Global Ophthalmic Anti-infective Preparations Price (MT) by Application (2023-2028) Table 53. North America Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) & (MT) Table 54. North America Ophthalmic Anti-infective Preparations Sales Market Share by Company (2017-2022) Table 55. North America Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) & (US$ Million) Table 56. North America Ophthalmic Anti-infective Preparations Revenue Market Share by Company (2017-2022) Table 57. North America Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT) Table 58. North America Ophthalmic Anti-infective Preparations Sales by Type (2023-2028) & (MT) Table 59. North America Ophthalmic Anti-infective Preparations Revenue by Type (2017-2022) & (US$ Million) Table 60. North America Ophthalmic Anti-infective Preparations Revenue by Type (2023-2028) & (US$ Million) Table 61. North America Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT) Table 62. North America Ophthalmic Anti-infective Preparations Sales by Application (2023-2028) & (MT) Table 63. North America Ophthalmic Anti-infective Preparations Revenue by Application (2017-2022) & (US$ Million) Table 64. North America Ophthalmic Anti-infective Preparations Revenue by Application (2023-2028) & (US$ Million) Table 65. North America Ophthalmic Anti-infective Preparations Sales by Country (2017-2022) & (MT) Table 66. North America Ophthalmic Anti-infective Preparations Sales by Country (2023-2028) & (MT) Table 67. North America Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022) & (US$ Million) Table 68. North America Ophthalmic Anti-infective Preparations Revenue by Country (2023-2028) & (US$ Million) Table 69. Europe Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) & (MT) Table 70. Europe Ophthalmic Anti-infective Preparations Sales Market Share by Company (2017-2022) Table 71. Europe Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) & (US$ Million) Table 72. Europe Ophthalmic Anti-infective Preparations Revenue Market Share by Company (2017-2022) Table 73. Europe Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT) Table 74. Europe Ophthalmic Anti-infective Preparations Sales by Type (2023-2028) & (MT) Table 75. Europe Ophthalmic Anti-infective Preparations Revenue by Type (2017-2022) & (US$ Million) Table 76. Europe Ophthalmic Anti-infective Preparations Revenue by Type (2023-2028) & (US$ Million) Table 77. Europe Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT) Table 78. Europe Ophthalmic Anti-infective Preparations Sales by Application (2023-2028) & (MT) Table 79. Europe Ophthalmic Anti-infective Preparations Revenue by Application (2017-2022) & (US$ Million) Table 80. Europe Ophthalmic Anti-infective Preparations Revenue by Application (2023-2028) & (US$ Million) Table 81. Europe Ophthalmic Anti-infective Preparations Sales by Country (2017-2022) & (MT) Table 82. Europe Ophthalmic Anti-infective Preparations Sales by Country (2023-2028) & (MT) Table 83. Europe Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022) & (US$ Million) Table 84. Europe Ophthalmic Anti-infective Preparations Revenue by Country (2023-2028) & (US$ Million) Table 85. Asia Pacific Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) & (MT) Table 86. Asia Pacific Ophthalmic Anti-infective Preparations Sales Market Share by Company (2017-2022) Table 87. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) & (US$ Million) Table 88. Asia Pacific Ophthalmic Anti-infective Preparations Revenue Market Share by Company (2017-2022) Table 89. Asia Pacific Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT) Table 90. Asia Pacific Ophthalmic Anti-infective Preparations Sales by Type (2023-2028) & (MT) Table 91. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Type (2017-2022) & (US$ Million) Table 92. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Type (2023-2028) & (US$ Million) Table 93. Asia Pacific Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT) Table 94. Asia Pacific Ophthalmic Anti-infective Preparations Sales by Application (2023-2028) & (MT) Table 95. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Application (2017-2022) & (US$ Million) Table 96. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Application (2023-2028) & (US$ Million) Table 97. Asia Pacific Ophthalmic Anti-infective Preparations Sales by Region (2017-2022) & (MT) Table 98. Asia Pacific Ophthalmic Anti-infective Preparations Sales by Region (2023-2028) & (MT) Table 99. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Region (2017-2022) & (US$ Million) Table 100. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Region (2023-2028) & (US$ Million) Table 101. Latin America Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) & (MT) Table 102. Latin America Ophthalmic Anti-infective Preparations Sales Market Share by Company (2017-2022) Table 103. Latin America Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) & (US$ Million) Table 104. Latin America Ophthalmic Anti-infective Preparations Revenue Market Share by Company (2017-2022) Table 105. Latin America Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT) Table 106. Latin America Ophthalmic Anti-infective Preparations Sales by Type (2023-2028) & (MT) Table 107. Latin America Ophthalmic Anti-infective Preparations Revenue by Type (2017-2022) & (US$ Million) Table 108. Latin America Ophthalmic Anti-infective Preparations Revenue by Type (2023-2028) & (US$ Million) Table 109. Latin America Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT) Table 110. Latin America Ophthalmic Anti-infective Preparations Sales by Application (2023-2028) & (MT) Table 111. Latin America Ophthalmic Anti-infective Preparations Revenue by Application (2017-2022) & (US$ Million) Table 112. Latin America Ophthalmic Anti-infective Preparations Revenue by Application (2023-2028) & (US$ Million) Table 113. Latin America Ophthalmic Anti-infective Preparations Sales by Country (2017-2022) & (MT) Table 114. Latin America Ophthalmic Anti-infective Preparations Sales by Country (2023-2028) & (MT) Table 115. Latin America Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022) & (US$ Million) Table 116. Latin America Ophthalmic Anti-infective Preparations Revenue by Country (2023-2028) & (US$ Million) Table 117. Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Company (2017-2022) & (MT) Table 118. Middle East and Africa Ophthalmic Anti-infective Preparations Sales Market Share by Company (2017-2022) Table 119. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Company (2017-2022) & (US$ Million) Table 120. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue Market Share by Company (2017-2022) Table 121. Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Type (2017-2022) & (MT) Table 122. Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Type (2023-2028) & (MT) Table 123. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Type (2017-2022) & (US$ Million) Table 124. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Type (2023-2028) & (US$ Million) Table 125. Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Application (2017-2022) & (MT) Table 126. Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Application (2023-2028) & (MT) Table 127. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Application (2017-2022) & (US$ Million) Table 128. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Application (2023-2028) & (US$ Million) Table 129. Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Country (2017-2022) & (MT) Table 130. Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Country (2023-2028) & (MT) Table 131. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Country (2017-2022) & (US$ Million) Table 132. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Country (2023-2028) & (US$ Million) Table 133. Allergan PLC Corporation Information Table 134. Allergan PLC Description and Overview Table 135. Allergan PLC Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 136. Allergan PLC Ophthalmic Anti-infective Preparations Product and Services Table 137. Allergan PLC Ophthalmic Anti-infective Preparations SWOT Analysis Table 138. Allergan PLC Recent Developments Table 139. Bayer AG Corporation Information Table 140. Bayer AG Description and Overview Table 141. Bayer AG Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 142. Bayer AG Ophthalmic Anti-infective Preparations Product and Services Table 143. Bayer AG Ophthalmic Anti-infective Preparations SWOT Analysis Table 144. Bayer AG Recent Developments Table 145. F. Hoffmann-La Roche AG Corporation Information Table 146. F. Hoffmann-La Roche AG Description and Overview Table 147. F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 148. F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Product and Services Table 149. F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations SWOT Analysis Table 150. F. Hoffmann-La Roche AG Recent Developments Table 151. Johnson and Johnson Vision Care Inc Corporation Information Table 152. Johnson and Johnson Vision Care Inc Description and Overview Table 153. Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 154. Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Product and Services Table 155. Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations SWOT Analysis Table 156. Johnson and Johnson Vision Care Inc Recent Developments Table 157. Kyowa Kirin Co., Ltd Corporation Information Table 158. Kyowa Kirin Co., Ltd Description and Overview Table 159. Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 160. Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Product and Services Table 161. Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations SWOT Analysis Table 162. Kyowa Kirin Co., Ltd Recent Developments Table 163. Novartis International AG Corporation Information Table 164. Novartis International AG Description and Overview Table 165. Novartis International AG Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 166. Novartis International AG Ophthalmic Anti-infective Preparations Product and Services Table 167. Novartis International AG Ophthalmic Anti-infective Preparations SWOT Analysis Table 168. Novartis International AG Recent Developments Table 169. Pfizer, Inc. Corporation Information Table 170. Pfizer, Inc. Description and Overview Table 171. Pfizer, Inc. Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 172. Pfizer, Inc. Ophthalmic Anti-infective Preparations Product and Services Table 173. Pfizer, Inc. Ophthalmic Anti-infective Preparations SWOT Analysis Table 174. Pfizer, Inc. Recent Developments Table 175. Regeneron Pharmaceuticals, Inc. Corporation Information Table 176. Regeneron Pharmaceuticals, Inc. Description and Overview Table 177. Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 178. Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Product and Services Table 179. Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations SWOT Analysis Table 180. Regeneron Pharmaceuticals, Inc. Recent Developments Table 181. Santen Pharmaceuticals Co., Ltd. Corporation Information Table 182. Santen Pharmaceuticals Co., Ltd. Description and Overview Table 183. Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 184. Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Product and Services Table 185. Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations SWOT Analysis Table 186. Santen Pharmaceuticals Co., Ltd. Recent Developments Table 187. Shire PLC Corporation Information Table 188. Shire PLC Description and Overview Table 189. Shire PLC Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 190. Shire PLC Ophthalmic Anti-infective Preparations Product and Services Table 191. Shire PLC Ophthalmic Anti-infective Preparations SWOT Analysis Table 192. Shire PLC Recent Developments Table 193. Bausch Health Corporation Information Table 194. Bausch Health Description and Overview Table 195. Bausch Health Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 196. Bausch Health Ophthalmic Anti-infective Preparations Product and Services Table 197. Bausch Health Recent Developments Table 198. Lupin Pharmaceuticals Corporation Information Table 199. Lupin Pharmaceuticals Description and Overview Table 200. Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 201. Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Product and Services Table 202. Lupin Pharmaceuticals Recent Developments Table 203. Apotex Corporation Information Table 204. Apotex Description and Overview Table 205. Apotex Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 206. Apotex Ophthalmic Anti-infective Preparations Product and Services Table 207. Apotex Recent Developments Table 208. Akorn Corporation Information Table 209. Akorn Description and Overview Table 210. Akorn Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022) Table 211. Akorn Ophthalmic Anti-infective Preparations Product and Services Table 212. Akorn Recent Developments Table 213. Key Raw Materials Lists Table 214. Raw Materials Key Suppliers Lists Table 215. Ophthalmic Anti-infective Preparations Distributors List Table 216. Ophthalmic Anti-infective Preparations Customers List Table 217. Research Programs/Design for This Report Table 218. Key Data Information from Secondary Sources Table 219. Key Data Information from Primary Sources List of Figures Figure 1. Ophthalmic Anti-infective Preparations Product Picture Figure 2. Global Ophthalmic Anti-infective Preparations Sales Market Share by Type in 2021 & 2028 Figure 3. Antibacterial Product Picture Figure 4. Antiviral Product Picture Figure 5. Antifungal Product Picture Figure 6. Anti-parasitic Product Picture Figure 7. Others Product Picture Figure 8. Global Ophthalmic Anti-infective Preparations Sales Market Share by Application in 2021 & 2028 Figure 9. Hospital Use Use Case Figure 10. Clinic Use Use Case Figure 11. Household Use Case Figure 12. Other Use Case Figure 13. Ophthalmic Anti-infective Preparations Report Years Considered Figure 14. Global Ophthalmic Anti-infective Preparations Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Ophthalmic Anti-infective Preparations Market Size 2017-2028 (US$ Million) Figure 16. Global Ophthalmic Anti-infective Preparations Sales (2017-2022) & (MT) Figure 17. Global Ophthalmic Anti-infective Preparations Market Size Market Share by Region: 2021 VS 2028 Figure 18. Global Ophthalmic Anti-infective Preparations Sales Market Share by Region (2017-2022) Figure 19. Global Ophthalmic Anti-infective Preparations Sales Market Share by Region in 2021 Figure 20. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Region in 2017 VS 2021 Figure 21. Global Ophthalmic Anti-infective Preparations Sales Share by Manufacturers in 2021 Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Ophthalmic Anti-infective Preparations Sales in 2021 Figure 23. Ophthalmic Anti-infective Preparations Revenue Share by Manufacturers in 2021 Figure 24. Ophthalmic Anti-infective Preparations Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 25. Global Ophthalmic Anti-infective Preparations Revenue Share by Type (2017-2022) Figure 26. Global Ophthalmic Anti-infective Preparations Revenue Growth Rate by Type in 2017 & 2021 Figure 27. Global Ophthalmic Anti-infective Preparations Revenue Share by Application (2017-2022) Figure 28. Global Ophthalmic Anti-infective Preparations Revenue Growth Rate by Application in 2017 & 2021 Figure 29. North America Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2028) Figure 30. North America Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2017-2028) Figure 31. North America Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2028) Figure 32. North America Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2017-2028) Figure 33. North America Ophthalmic Anti-infective Preparations Sales Share by Country (2017-2028) Figure 34. North America Ophthalmic Anti-infective Preparations Revenue Share by Country (2017-2028) Figure 35. U.S. Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 36. Canada Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 37. Europe Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2028) Figure 38. Europe Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2017-2028) Figure 39. Europe Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2028) Figure 40. Europe Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2017-2028) Figure 41. Europe Ophthalmic Anti-infective Preparations Sales Share by Country (2017-2028) Figure 42. Europe Ophthalmic Anti-infective Preparations Revenue Share by Country (2017-2028) Figure 43. Germany Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 44. France Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 45. U.K. Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 46. Italy Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 47. Russia Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 48. Asia Pacific Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2028) Figure 49. Asia Pacific Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2017-2028) Figure 50. Asia Pacific Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2028) Figure 51. Asia Pacific Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2017-2028) Figure 52. Asia Pacific Ophthalmic Anti-infective Preparations Sales Share by Region (2017-2028) Figure 53. Asia Pacific Ophthalmic Anti-infective Preparations Revenue Share by Region (2017-2028) Figure 54. China Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 55. Japan Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 56. South Korea Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 57. India Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 58. Australia Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 59. Taiwan Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 60. Indonesia Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 61. Thailand Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 62. Malaysia Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 63. Philippines Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 64. Vietnam Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 65. Latin America Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2028) Figure 66. Latin America Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2017-2028) Figure 67. Latin America Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2028) Figure 68. Latin America Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2017-2028) Figure 69. Latin America Ophthalmic Anti-infective Preparations Sales Share by Country (2017-2028) Figure 70. Latin America Ophthalmic Anti-infective Preparations Revenue Share by Country (2017-2028) Figure 71. Mexico Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 72. Brazil Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 73. Argentina Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 74. Middle East and Africa Ophthalmic Anti-infective Preparations Sales Market Share by Type (2017-2028) Figure 75. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2017-2028) Figure 76. Middle East and Africa Ophthalmic Anti-infective Preparations Sales Market Share by Application (2017-2028) Figure 77. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2017-2028) Figure 78. Middle East and Africa Ophthalmic Anti-infective Preparations Sales Share by Country (2017-2028) Figure 79. Middle East and Africa Ophthalmic Anti-infective Preparations Revenue Share by Country (2017-2028) Figure 80. Turkey Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 81. Saudi Arabia Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 82. UAE Ophthalmic Anti-infective Preparations Revenue (2017-2028) & (US$ Million) Figure 83. Ophthalmic Anti-infective Preparations Value Chain Figure 84. Ophthalmic Anti-infective Preparations Production Process Figure 85. Channels of Distribution Figure 86. Distributors Profiles Figure 87. Bottom-up and Top-down Approaches for This Report Figure 88. Data Triangulation Figure 89. Key Executives Interviewed

Allergan PLC Bayer AG F. Hoffmann-La Roche AG Johnson and Johnson Vision Care Inc Kyowa Kirin Co., Ltd Novartis International AG Pfizer, Inc. Regeneron Pharmaceuticals, Inc. Santen Pharmaceuticals Co., Ltd. Shire PLC Bausch Health Lupin Pharmaceuticals Apotex Akorn